Evidence map›Paper›PMID 21455639›Full record

ArticleEndocrine2011

Allopregnanolone induces LHRH and glutamate release through NMDA receptor modulation.

Fernando A Giuliani, Roberto Yunes, Claudia E Mohn, Myriam Laconi, Valeria Rettori, Ricardo Cabrera

Abstract read
PubMed Publisher
In one paragraph

Article in Endocrine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Allopregnanolone: Metabolism, Mechanisms of Action, and Its Role in Cancer.International journal of molecular sciences · 2022
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Hormonal regulation of female reproduction.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 2012
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Fernando A GiulianiInstituto de Investigaciones Biomédicas, Universidad de Mendoza, IMBECU-CONICET, Paseo Dr. Emilio Descotte 720, 5500, Mendoza, Argentina.
Roberto Yunes
Claudia E Mohn
Myriam Laconi
Valeria Rettori
Ricardo Cabrera
University of Mendoza · ARConsejo Nacional de Investigaciones Científicas y Técnicas · ARUniversity of Buenos Aires · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

LHRH release from hypothalamus is influenced by the neurotransmitter glutamate that acts, among others, on NMDA receptors present in LHRH neurons. On the other hand, the neurosteroid allopregnanolone can modulate the activity of specific neurotransmitter receptors and affect neurotransmitter release. We examined the role of allopregnanolone on in vitro LHRH and glutamate release from mediobasal hypothalamus and anterior preoptic area of ovariectomized rats with estrogen and progesterone replacement. Moreover, we evaluated whether the neurosteroid might act through modulation of NMDA receptors. Allopregnanolone induced an increase in LHRH release. This effect was reversed when the NMDA receptors were blocked by the NMDA antagonist 2-amino-7-phosphonoheptanoic acid (AP-7) indicating that this neurosteroid would interact with NMDA receptors. Moreover allopregnanolone induced an augment in K(+) evoked [(3)H]-glutamate release from mediobasal hypothalamus-anterior preoptic area explants and this effect was also reversed when NMDA receptors were blocked with AP-7. These results suggest an important physiologic function of allopregnanolone on the regulation of neuroendocrine function in female adult rats. Not only appears to be involved in enhancing LHRH release through modulation of NMDA receptors but also in the release of glutamate which is critical in the control of LHRH release.

Indexed as

2-Amino-5-phosphonovalerateAnimalsEstrogen Replacement TherapyFemaleGlutamic AcidGonadotropin-Releasing HormoneHypothalamusIn Vitro TechniquesModels, AnimalNeurotransmitter AgentsN-MethylaspartateOvariectomyPregnanolonePreoptic AreaRatsRats, Sprague-Dawley2-Amino-5-phosphonovalerate2-amino-7-phosphonoheptanoic acidGlutamic AcidGonadotropin-Releasing HormoneNeurotransmitter AgentsN-MethylaspartatePregnanoloneReceptors, N-Methyl-D-Aspartate

Identifiers

PMID21455639
OpenAlexW1975368231

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.